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Abstract 
Osteoporosis is as a very complex multi-factorial pathogenesis; 
thereby any doctor facing a case of osteoporosis must be very careful. 
Diagnostic procedures are complex and include careful monitoring of the 
history of patient, physical examination and some laboratory analysis. In this 
study, 201 patients aged between 50 and 95 years were selected from 4872 
patients consulting orthopedic clinics. This group (201 patients: 168 women, 
33 men) showed evidence of osteoporosis: BMD DXA with reduced bone 
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mineral density,T-score: greater than -2.5 SD, or X-ray signs of non 
traumatic fractures. Patients also underwent biochemical and instrumental 
investigations for an assessment of bone metabolism. Age, gender, medical 
history as well as tests of rheumatic metabolism, calcium-phosphorus and 
some indices of bone turnover were determined for each patient. 
Interestingly, our data showed that 104 patients had a vertebral fracture 
without trauma, 22 hypothyroid patients were undergoing treatment with 
levothyroxine, 3 patients were suffering from autoimmune thyroiditis, 3 
patients were suffering from secondary hyperparathyroidism with vitamin D 
deficiency, 2 patients were suffering from adenoma with primary 
hyperparathyroidism, 20 were diabetic patients, 7 patients had monoclonal 
gammopathy, 7 women had hystero- ovario salpingectomy, 7 patients were 
HCV positive, 4 patients with rheumatoid arthritis had been treated with 
corticosteroids, 2 patients were suffering from multiple myeloma, and 1 
patient had Crohn's disease.  There was also 1 suspected case of ulcerative 
colitis, 5 patients were suffering from celiac disease and other cases 
described in the paper. 
 As a result of this diverse association, the approach to treating 
osteoporotic patients should be then accurate and multidisciplinary. It is then 
important to perform laboratory tests and investigations for correct diagnosis 
and adequate treatment. 
 
Keywords: Bone mineral density (BMD), Celiac disease (CD), Standard 
deviation (SD), Dual-energy X-ray Absorptiometry (DXA), Hepatitis C virus 
(HCV), and Erythrocyte sedimentation rate (ESR), C- reactive protein 
(CRP), Tuberculosis (TB). 
 
Introduction 
 Diagnostic procedures of osteoporosis are complex; they include 
accurate documentation of the history of the patient, and carrying out 
physical examinations and laboratory analysis. This approach is the only way 
to differentiate between primary and secondary osteoporosis (reaching 35% 
of the cases in women and 20 -50% in men). Moreover, it allows a proper 
diagnosis for a subsequently correct treatment. The clinical relevance of 
secondary osteoporosis can be understood as an event in the course of a 
disease or an epiphenomenon already manifested clinically as primary 
manifestation of systemic diseases.  
 The classification of secondary osteoporosis cannot be done without 
taking into consideration the different nosographic groups. This helps to 
emphasize the multidisciplinary approach of this event in particular caused 
by endocrine, iatrogenic consequences, rheumatologic, dysmetabolic, 
gastroenterological, celiac disease, proliferative hematological cancer, or 
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proliferative diseases in addition to pharmacological treatment. Several 
varied conditions can potentially support secondary osteoporosis like, 
hormonal imbalances (hyperadrenalism, hyperparathyroidism, 
hyperthyroidism, hypogonadism, hyperprolactinemia, diabetes), intake of 
certain categories of drugs (corticosteroids, ethanol, phenytoin, tobacco, 
barbiturates, heparin), in addition to  circumstances that favor the 
development of the disease, such as prolonged immobilization, chronic 
kidney failure, liver disease, malabsorption syndromes, pulmonary chronic 
obstructive pulmonary disease, rheumatoid arthritis, sarcoidosis, malignant 
tumors, or prolonged absences of gravity.  
 Secondary osteoporosis is clinically common to many diseases and 
can be the first manifestation of several diseases. It may then become a good 
diagnostic key in all patients suffering from osteoporosis at a young age, or a 
bone disease not related to menopausal status and / or age. Therefore, an 
imperative clinical screening associated with laboratory tests is necessary to 
determine the cause of the disease or the associated conditions and give the 
necessary treatment. 
 
Aim of the research: 
 Based on the considerations outlined above, the purpose of this study 
is to demonstrate the high incidence of secondary osteoporosis; the 
importance of a correct diagnosis and a proper multidisciplinary approach in 
patients with radiographic signs of vertebral collapse and / or bone fractures 
(femur, humerus, radius, vertebrae) without trauma and /or signs of 
osteoporosis BMD, is not limited only to healing, but to better specify 
whether we are facing a state of primitive   and / or secondary osteoporosis 
and consequently for an adequate treatment. Even patients, unrelated to 
osteoporosis, who are seen occasionally with a request for orthopedic 
specialist advice (prescription for an adjuvant, example: the brace) deserve to 
be better studied. 
 
Patients and methods: 
 201 patients were selected from a total of 4872 within five years 
(from December 2002 to February 2008) in the clinic of Orthopedic Surgery 
in Borgo San Lorenzo at the Center of Polyvalent Social Health, Florence, 
Italy. These 4872 patients referred to our Center are aged between 3 and 95 
years. Among them only 201 patients aged between 50 and 95 years (168 
women, 33 men) had evidence of osteoporosis: BMD DXA with reduction of 
bone mineral density, with T-score: greater than -2.5 SD or X-ray signs of 
non traumatic fractures. 
 These patients underwent biochemical and instrumental 
investigations for an assessment of bone metabolism. On their first visit, age, 
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gender, and medical history were determined for each patient. Moreover, 
laboratory tests of rheumatic metabolism and calcium-phosphorus (complete 
blood count, ESR, CRP, uric acid, creatinine, blood urea nitrogen, serum 
calcium, phosphorus, magnesium, serum protein electrophoresis, serum 
electrolytes) and some indices of bone turnover (total alkaline phosphatase 
and bone, urinary calcium (24hr), phosphaturia, 25- (OH) - and 1,25- ( OH) 
2-vit.D3, parathyroid hormone) were done.  
 Patients were divided in five groups according to the age: 50 to 60 
years, 60 to 70, 70 to 80, 80 to 90 and 90 to 100. From 50 to 60 years we had 
12 patients: 9 women and 3 men, from 60 to 70 years 43 patients: 34 women 
and 9 men, from 70 to 80 years 95 patients: 80 women and 15 men, from 80 
to 90 years 50 patients: 44 women and 6 men and from 90 to 100 one woman 
only between. The report showed that the group with higher incidence is 
represented by 95 patients aged between 70 and 80 years, followed by the 
group aged between 80 and 90 years, adding up to a total of 50 patients. The 
last age group includes patients aged between 60 and 70 years for a total of 
43 patients.  
Table 1. Age groups of patients. 
 
Statistical analysis:  
 201 patients aged between 50 and 95 years, including 168 women 
and 33 men, had BMD / DXA with reduction in bone mineral density, with 
T-score greater than -2.5 or osteoporosis with signs of fractures without 
previous trauma on X RAY. Data from this study shows: 104 patients having 
vertebral collapse without a trauma, 22 hypothyroid patients on Eutirox, 3 
suffering from autoimmune based thyroiditis, 3 diabetics with 
hypothyroidism, 3 suffering from hyperparathyroidism secondary to Vitamin 
D deficiency, 2 having primary hyperparathyroidism with parathyroid 
adenoma, 1 diabetic having hypertension and hypothyroidism, 3 cases of 
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hyperthyroidism treated with methimazole. 31 patients suffering from 
arterial hypertension, 20 diabetics, 7 diabetic and hypertensive patients and 7  
cases of monoclonal gammopathy, 7 women who have had hystero ovario 
salpyngectomy, 7-HCV positive, 4 rheumatoid arthritis  therapy with 
corticosteroids, 1 suffering from chronic liver disease, 5 patients 
continuously receiving glucocortisteroids, 1 patient suffering from 
plasmacytoma, 2 multiple Myeloma patients, 1 Suffering from active chronic 
hepatitis, 1 patient having TB, 1 patient suffering from Crohn's  Disease, 1  
case of ulcerative colitis, 5 cases of celiac disease, 2 suffering from 
Parkinson disease, 1 suffering from  Alzheimer Disease, 1 lymphoma, 1 
ankylosing spondylitis, 1 on amiodarone therapy, 5 on Phenobarbital and 
phenytoin therapy, 1 case of psoriatic arthritis, 1 who had nephrectomy, 1 
suffering from intervention outcomes of  recto-sigmoid anastomosis and 4  
asthmatics. 
Table 2.Diseases and conditions associated with secondary osteoporosis. 
 
Special cases: 
 In our study series, patients without instrumental BMD evidence of 
osteoporosis or non traumatic fractures visible on X Ray have been excluded. 
From the 4872 patients seen in our orthopedic Center, 201 patients had 
fractures of the femur, post-traumatic vertebral collapse or signs of 
osteoporosis with BMD DXA T score: greater than -2.5. For correct 
diagnosis of osteoporosis, accurate documentation of history and physical 
examination should be done to evaluate the risk factors and exclude 
secondary forms of the disease. A proper metabolic evaluation should be 
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performed to exclude other skeletal metabolic diseases and secondary forms 
of the disease that occur with the reduction of bone mineral densitometry. In 
addition to the instrumental evaluation and radiography to reveal any 
asymptomatic vertebral fractures. 
 
Conclusion:  
 The approach to osteoporotic patients should be accurate and 
multidisciplinary. Many patients studied in our research had vertebral 
fractures, parathyroid and thyroid disease, but had not been considered as 
cases of osteoporosis.  It is so important to perform laboratory tests for 
correct diagnosis and adequate treatment. Given the frequency with which 
this complication occurs in the cases mentioned above, it is essential to 
establish a "surveillance" follow up from the outset designed to detect signs 
of osteoporosis as early as possible so it is important for patients at risk to 
carry out blood tests and Radiographs at regular intervals in order to closely 
monitor on one hand the bone metabolism, and on the other its conformation. 
Again, it is therefore essential for the doctor to be aware of the possibility of 
the onset of secondary osteoporosis in certain circumstances, and 
immediately put in place a suitable monitoring protocol.  It is very important 
to have a correct diagnosis and a proper multidisciplinary approach for a 
patient with radiographic signs of vertebral collapse and / or fragility 
fractures. The clinical relevance of secondary osteoporosis can be understood 
both as an event in the course of a disease already manifested or an 
epiphenomenon clinical initiation of systemic diseases for which 
osteoporosis may be a key for initial diagnosis. 
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